These biomarkers have been proved to have potential for monitoring the treatment of that disease, and are related with an improvement in inflammation and renal damage
Bioiberica has recently completed a test with dogs suffering from leishmaniasis that had been treated with Impromune®, a product based on nucleotides and AHCC, which showed better results than the standard treatment
Optimus and Armurox increase sucrose contexts and sugar cane yield, respectively